Overview

Prevention of Arrhythmia Device Infection Trial (PADIT)

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The goal of the pilot study is to compare whether a centre-wide policy of incremental antibiotic therapy will reduce pacemaker infection compared to a policy of conventional antibiotic prophylaxis in high-risk patients undergoing arrhythmia device procedures. This pilot study will provide feasibility information for a larger cluster randomized crossover design (CRCD).
Phase:
Phase 4
Details
Lead Sponsor:
Population Health Research Institute
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Bacitracin
Cefazolin
Cephalexin
Clindamycin
Clindamycin palmitate
Clindamycin phosphate
Vancomycin